Recipient Title Business Head-Pharmaceuticals, Dhirubhai Ambani Life Sciences Centre R-282 Ttc Area of MIDC, Thane Belapur Road, Rabale Navi Mumbai 400701 Maharashtra India, (b)(6)FEI 3009510975Issued Aug 18, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3009510975.
Violations3
Issue DateAug 18, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Reliance Life Sciences Private Limited
Location
Recipient Title Business Head-Pharmaceuticals, Dhirubhai Ambani Life Sciences Centre R-282 Ttc Area of MIDC, Thane Belapur Road, Rabale Navi Mumbai 400701 Maharashtra India, (b)(6)
FEI Number
3009510975
Country
India
Issue Date
August 18, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Reliance Life Sciences Private Limited FDA Warning Letter, August 18, 2026
Talk to a Specialist